Skip to main content
Terug
Watch Compare

Annovis Bio, Inc.

Datakwaliteit: 100%
ANVS
NYSE Manufacturing Chemicals
€ 1,59
▼ € 0,03 (-1,85%)
Marktkapitalisatie: 46,29 M
Prijs
€ 1,63
Marktkapitalisatie
46,29 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -25,62 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-183,28%
Onder sectorgemiddelde (-53,34%)
ROIC-146,14%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Waardering

PE (TTM)
-1,60
Onder sectorgemiddelde (-1,47)
P/B Ratio3,52
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,6 -1,5
P/B 3,5 1,6
ROE % -183,3 -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

2 analisten
Strong Buy
Huidig
€ 1,59
+686.2%
Koersdoel
€ 12,50
€ 8,00
€ 12,50
€ 17,00
Vooruitzicht
Forward K/W -1,47
Forward WPA -€ 1,08
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 1,08
-€ 1,08 – -€ 1,08
 0,0 1
FY2026 -€ 1,10
-€ 1,10 – -€ 1,10
 0,0 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,30 -€ 0,39 -30,0%
Q32025 -€ 0,37 -€ 0,37 0,0%
Q22025 -€ 0,39 -€ 0,32 +18,0%
Q12025 -€ 0,29 -€ 0,32 -10,3%

ETFs Holding This Stock

BRSIX BRSIX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -28,85 M
ROE -183,28% ROA -149,34%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -25,62 M
ROIC -146,14% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 0,00
Working Capital N/A Tangible Book Value 13,16 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,60 Forward P/E N/A
P/B Ratio 3,52 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55,34%
Market Cap 46,29 M Enterprise Value 31,01 M
Per Share
EPS (Diluted TTM) -1,40 Revenue / Share 0,00
FCF / Share -0,90 OCF / Share -0,90
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88,79%
SBC-Adj. FCF -27,45 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -28,85 M -24,59 M -56,20 M -25,33 M -14,49 M
EPS (Diluted) -1,40 -2,31 -6,23 -3,10 -1,90
Gross Profit — — — — —
Operating Income -29,70 M -26,69 M -45,04 M -25,51 M -14,54 M
EBITDA — — — — —
R&D Expenses 25,22 M 20,00 M 38,79 M 16,52 M 8,48 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21,08 M 13,93 M 10,21 M 36,02 M 46,00 M
Total Liabilities 4,23 M 4,62 M 17,96 M 7,70 M 1,51 M
Shareholders' Equity 16,85 M 9,31 M -7,75 M 28,32 M 44,49 M
Total Debt — — — — —
Cash & Equivalents 19,53 M 10,55 M 5,75 M 28,38 M 45,69 M
Current Assets — — 10,21 M 36,02 M 46,00 M
Current Liabilities 3,64 M 3,88 M 4,28 M 7,70 M 1,51 M